Taysha Gene Therapies (TSHA) Debt to Equity (2019 - 2026)
Taysha Gene Therapies (TSHA) debt to equity from Sep 30, 2019 to Mar 31, 2026. The current Taysha Gene Therapies (TSHA) debt to equity is 23.10%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Taysha Gene Therapies (TSHA)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | 20.29% | -66.97% |
| 2024 | 61.43% | +13.64% |
| 2023 | 54.06% | -98.65% |
| 2022 | 3996.84% | +10150.57% |
| 2021 | 38.99% | N/A |
| 2019 | 0.00% | N/A |
Comparison Taysha Gene Therapies (TSHA) debt to equity with competitors
Taysha Gene Therapies (TSHA) debt to equity is 23.10%.